| Dr Samuel Nelson Sigoloff, DO | |
|
4290 S Silva Dr, Sierra Vista, AZ 85650-8830 | |
| (210) 872-1357 | |
| Not Available |
| Full Name | Dr Samuel Nelson Sigoloff |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 4290 S Silva Dr, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629486154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1149 (Nebraska) | Secondary |
| 207Q00000X | Family Medicine | S3747 (Texas) | Primary |
| Entity Name | Carnett Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790961167 PECOS PAC ID: 5890732655 Enrollment ID: O20050413000307 |
News Archive
The Veterans' Administration should expect a high volume of Iraq veterans seeking treatment of post traumatic stress disorder, with researchers anticipating that the rate among armed forces will be as high as 35%, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS-).
A survey of almost 22,000 admitted patients at the University of Chicago Medical Center found patient preference to participate in decision making concerning their care was associated with a longer length of stay and higher total hospitalization costs, according to a report published online by JAMA Internal Medicine.
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
The hormone testosterone stands for typically male attributes - it fosters the forming of the sexual characteristics, increases libido and muscle building. Women also have this sex hormone, but to a much lesser extent.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Nelson Sigoloff, DO 7950 Martin Loop, Columbus, GA 31905-5648 Ph: (706) 544-1554 | Dr Samuel Nelson Sigoloff, DO 4290 S Silva Dr, Sierra Vista, AZ 85650-8830 Ph: (210) 872-1357 |
News Archive
The Veterans' Administration should expect a high volume of Iraq veterans seeking treatment of post traumatic stress disorder, with researchers anticipating that the rate among armed forces will be as high as 35%, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS-).
A survey of almost 22,000 admitted patients at the University of Chicago Medical Center found patient preference to participate in decision making concerning their care was associated with a longer length of stay and higher total hospitalization costs, according to a report published online by JAMA Internal Medicine.
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
The hormone testosterone stands for typically male attributes - it fosters the forming of the sexual characteristics, increases libido and muscle building. Women also have this sex hormone, but to a much lesser extent.
› Verified 9 days ago
Ralph Esker Mayberry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Wilcox Dr, Sierra Vista, AZ 85635 Phone: 520-459-3116 Fax: 520-459-7397 | |
Dr. Jeffrey Virgil Wilde, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 El Camino Real Bldg 11, Sierra Vista, AZ 85635 Phone: 520-255-5475 Fax: 855-801-7998 | |
Dr. Franklin Terry Perkins Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3533 Canyon De Flores Ste A, Sierra Vista, AZ 85650 Phone: 520-685-3336 | |
Dr. Parag Rasik Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 126 S Coronado Dr, Suite B, Sierra Vista, AZ 85635 Phone: 520-439-0115 Fax: 520-458-3016 | |
Louise Nosanchuck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 E Fry Blvd, Sierra Vista, AZ 85635 Phone: 520-459-8915 Fax: 520-458-9424 | |
Mark Christian Carnett, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Calle Portal, Suite 600, Sierra Vista, AZ 85635 Phone: 520-439-5186 Fax: 520-439-4466 | |
Dr. Natalie Rose Krumdieck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Calle Portal Ste 300, Sierra Vista, AZ 85635 Phone: 520-459-3011 Fax: 520-364-4261 |